rs7788778

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002291.3(LAMB1):​c.2109+128A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.298 in 1,000,462 control chromosomes in the GnomAD database, including 46,990 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.25 ( 5659 hom., cov: 32)
Exomes 𝑓: 0.31 ( 41331 hom. )

Consequence

LAMB1
NM_002291.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.00

Publications

9 publications found
Variant links:
Genes affected
LAMB1 (HGNC:6486): (laminin subunit beta 1) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 1. The beta 1 chain has 7 structurally distinct domains which it shares with other beta chain isomers. The C-terminal helical region containing domains I and II are separated by domain alpha, domains III and V contain several EGF-like repeats, and domains IV and VI have a globular conformation. Laminin, beta 1 is expressed in most tissues that produce basement membranes, and is one of the 3 chains constituting laminin 1, the first laminin isolated from Engelbreth-Holm-Swarm (EHS) tumor. A sequence in the beta 1 chain that is involved in cell attachment, chemotaxis, and binding to the laminin receptor was identified and shown to have the capacity to inhibit metastasis. [provided by RefSeq, Aug 2011]
LAMB1 Gene-Disease associations (from GenCC):
  • cobblestone lissencephaly without muscular or ocular involvement
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, PanelApp Australia, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 7-107961078-T-C is Benign according to our data. Variant chr7-107961078-T-C is described in ClinVar as Benign. ClinVar VariationId is 682976.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002291.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMB1
NM_002291.3
MANE Select
c.2109+128A>G
intron
N/ANP_002282.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMB1
ENST00000222399.11
TSL:1 MANE Select
c.2109+128A>G
intron
N/AENSP00000222399.6
LAMB1
ENST00000393560.5
TSL:1
c.2109+128A>G
intron
N/AENSP00000377190.1
LAMB1
ENST00000677793.1
c.2109+128A>G
intron
N/AENSP00000504020.1

Frequencies

GnomAD3 genomes
AF:
0.253
AC:
38406
AN:
151920
Hom.:
5661
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0977
Gnomad AMI
AF:
0.379
Gnomad AMR
AF:
0.253
Gnomad ASJ
AF:
0.297
Gnomad EAS
AF:
0.255
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.355
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.324
Gnomad OTH
AF:
0.263
GnomAD4 exome
AF:
0.306
AC:
259736
AN:
848424
Hom.:
41331
AF XY:
0.307
AC XY:
132944
AN XY:
433624
show subpopulations
African (AFR)
AF:
0.0900
AC:
1829
AN:
20320
American (AMR)
AF:
0.289
AC:
7208
AN:
24982
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
4698
AN:
16874
East Asian (EAS)
AF:
0.255
AC:
8995
AN:
35300
South Asian (SAS)
AF:
0.270
AC:
15273
AN:
56566
European-Finnish (FIN)
AF:
0.351
AC:
14445
AN:
41144
Middle Eastern (MID)
AF:
0.307
AC:
1020
AN:
3322
European-Non Finnish (NFE)
AF:
0.319
AC:
194701
AN:
610534
Other (OTH)
AF:
0.294
AC:
11567
AN:
39382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
8734
17468
26202
34936
43670
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4808
9616
14424
19232
24040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.253
AC:
38413
AN:
152038
Hom.:
5659
Cov.:
32
AF XY:
0.254
AC XY:
18838
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.0977
AC:
4055
AN:
41504
American (AMR)
AF:
0.253
AC:
3870
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.297
AC:
1029
AN:
3468
East Asian (EAS)
AF:
0.256
AC:
1317
AN:
5154
South Asian (SAS)
AF:
0.283
AC:
1361
AN:
4814
European-Finnish (FIN)
AF:
0.355
AC:
3748
AN:
10568
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.324
AC:
22040
AN:
67946
Other (OTH)
AF:
0.259
AC:
545
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1405
2810
4215
5620
7025
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
402
804
1206
1608
2010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.301
Hom.:
13713
Bravo
AF:
0.239
Asia WGS
AF:
0.247
AC:
856
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.087
DANN
Benign
0.46
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7788778; hg19: chr7-107601523; API